Physician profile
John Ho
NPI 1043508443
$2,342.22
in general payments reported to CMS, 2019-2025
19 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,051 · 2020: $110 · 2021: $457 · 2022: $131 · 2023: $144 · 2024: $324 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $451.87 | 2019-2021 | |
| Allergan, INC. | $426.70 | 2021 | |
| Sientra, INC. | $239.34 | 2019 | |
| Endo Pharmaceuticals INC. | $172.18 | 2019-2024 | Xiaflex |
| Abbvie INC. | $172.02 | 2020-2023 | |
| Galderma Laboratories, L.P. | $130.54 | 2022 | |
| Ucb, INC. | $125.00 | 2025 | Bimzelx |
| Novo Nordisk INC | $124.72 | 2024 | |
| W. L. Gore & Associates, INC. | $119.30 | 2019-2020 | |
| Kerecis Limited | $87.50 | 2019 | |
| Dermira, INC. | $55.71 | 2019 | |
| Melinta Therapeutics, LLC | $51.12 | 2019 | |
| Janssen Biotech, INC. | $49.68 | 2024 | Simponi Aria, Tremfya, Stelara |
| Biofrontera INC. | $41.79 | 2019-2020 | |
| Tei Biosciences INC | $26.33 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.93 | 2019 | |
| Medtronic USA, INC. | $16.24 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.70 | 2019 | |
| Bioventus LLC | $13.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.